Lung cancer in never-smokers - what are the differences?

Area of Science:

• Oncology
• Genetics
• Epidemiology

Background:

• Characteristics of lung cancer in never-smokers remain under-explored.
• Understanding these differences is crucial for targeted treatment strategies.

Purpose of the Study:

• To compare demographic, clinical, and molecular features of non-small cell lung cancer (NSCLC) between never-smokers and ever-smokers.
• To identify distinct characteristics that may indicate different underlying disease mechanisms.

Main Methods:

• Retrospective cohort study including newly diagnosed NSCLC patients with known smoking status (2011-2015).
• Comparison of clinical, histological, and molecular data between never-smoker and ever-smoker groups.

Main Results:

• Never-smokers (22.4%) were more likely to be female, older, and diagnosed with adenocarcinoma.
• Never-smokers experienced diagnostic delays and showed distinct metastatic patterns (e.g., more pleural metastases).
• Higher prevalence of ALK translocations (26% vs. 4%) and EGFR mutations (36% vs. 8%) observed in never-smokers, with differing EGFR mutation types.

Conclusions:

• Never-smokers with NSCLC exhibit distinct demographic and clinical profiles compared to ever-smokers.
• Tumor molecular characteristics, including genetic mutations, differ significantly, suggesting unique carcinogenic pathways in never-smokers.